This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Transactions

Dec. 18, 2001

Dewey Ballantine: MEDIMMUNE BUYS MAKER OF NASAL SPRAY FLU VACCINE

MedImmune Inc. announced Dec. 2 its acquisition of Aviron. The deal was worth $1.5 billion in stock. Gaithersburg, Md.-based MedImmune develops and sells vaccines. The company's signature product, Synagis, is a vaccine used to prevent pneumonia and bronchitis in infants.

        MedImmune Inc. announced Dec. 2 its acquisition of Aviron. The deal was worth $1.5 billion in stock.
        Gaithersburg, Md.-based MedImmune develops and sells vaccines. The company's signature product, Synagis, is a vaccine used to prevent pneumonia and bronchitis in infants.
        Mountain View's Aviron develops vaccines using live v...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up